For a long time our team has believed that Botox has a much higher adverse event rate than published in manufacture labeling. Our support group has 28k+ people suffering from over 10 countries around the world.
In May of 2022, researchers in the UK completed an meta-analysis that assessed the "safety profile of cosmetic glabellar and forehead BoNT-A injections and to evaluate BoNT-A type complication rate."
This study is important because the manufacture warning label states that reactions to Botox are only 1-2%. The findings of a 16% reaction rate, or 1 in 6 paints an ENTIRELY different safety profile for botulinum toxin injections!
For a summary of this study, read the article, "Botox leads to bad reactions for one in six users, study says" by The Guardian.
Please read the study FULL TEXT published in Aesthetics Surgery Journal
HERE:
Comments